Privia Health Group, Inc. (NASDAQ:PRVA) Receives Average Rating of “Moderate Buy” from Brokerages

Privia Health Group, Inc. (NASDAQ:PRVA) has earned an average rating of “Moderate Buy” from the sixteen brokerages that are currently covering the company, Marketbeat.com reports. Three analysts have rated the stock with a hold rating and thirteen have issued a buy rating on the company. The average twelve-month price objective among brokers that have issued ratings on the stock in the last year is $30.50.

Several research analysts have commented on PRVA shares. BMO Capital Markets began coverage on Privia Health Group in a report on Thursday, November 13th. They set an “outperform” rating and a $30.00 target price on the stock. Citigroup reiterated a “market outperform” rating on shares of Privia Health Group in a report on Tuesday, January 6th. JPMorgan Chase & Co. upped their price target on shares of Privia Health Group from $32.00 to $33.00 and gave the company an “overweight” rating in a research report on Thursday, November 13th. Weiss Ratings reissued a “hold (c)” rating on shares of Privia Health Group in a research report on Monday, December 29th. Finally, Evercore ISI boosted their price objective on Privia Health Group from $28.00 to $30.00 and gave the company an “outperform” rating in a research note on Friday, November 7th.

Insider Buying and Selling

In other Privia Health Group news, CFO David Mountcastle sold 23,887 shares of the stock in a transaction that occurred on Friday, December 12th. The stock was sold at an average price of $25.03, for a total transaction of $597,891.61. Following the transaction, the chief financial officer directly owned 172,909 shares in the company, valued at approximately $4,327,912.27. This represents a 12.14% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Matthew Shawn Morris sold 13,647 shares of the firm’s stock in a transaction on Friday, December 12th. The stock was sold at an average price of $25.01, for a total transaction of $341,311.47. Following the completion of the sale, the director owned 68,188 shares of the company’s stock, valued at $1,705,381.88. The trade was a 16.68% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 10.70% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. State of Alaska Department of Revenue boosted its stake in shares of Privia Health Group by 1.3% in the 4th quarter. State of Alaska Department of Revenue now owns 65,747 shares of the company’s stock worth $1,558,000 after buying an additional 823 shares during the last quarter. Choreo LLC increased its holdings in Privia Health Group by 9.3% in the 4th quarter. Choreo LLC now owns 13,396 shares of the company’s stock worth $320,000 after acquiring an additional 1,141 shares during the last quarter. Harbor Capital Advisors Inc. grew its position in shares of Privia Health Group by 13.5% in the fourth quarter. Harbor Capital Advisors Inc. now owns 41,761 shares of the company’s stock valued at $990,000 after purchasing an additional 4,955 shares in the last quarter. SG Americas Securities LLC boosted its position in shares of Privia Health Group by 124.8% in the fourth quarter. SG Americas Securities LLC now owns 23,024 shares of the company’s stock valued at $546,000 after acquiring an additional 12,780 shares during the period. Finally, Park Avenue Securities LLC boosted its holdings in Privia Health Group by 23.0% in the 4th quarter. Park Avenue Securities LLC now owns 17,507 shares of the company’s stock valued at $415,000 after purchasing an additional 3,272 shares during the period. Institutional investors and hedge funds own 94.48% of the company’s stock.

Privia Health Group Trading Down 0.1%

NASDAQ:PRVA opened at $23.94 on Friday. The stock’s 50-day moving average is $23.82 and its 200-day moving average is $23.07. Privia Health Group has a 1-year low of $18.77 and a 1-year high of $26.51. The stock has a market cap of $2.94 billion, a P/E ratio of 184.17, a price-to-earnings-growth ratio of 1.68 and a beta of 0.83.

Privia Health Group (NASDAQ:PRVA) last posted its earnings results on Thursday, November 6th. The company reported $0.29 EPS for the quarter, topping the consensus estimate of $0.06 by $0.23. The business had revenue of $580.42 million for the quarter, compared to the consensus estimate of $494.98 million. Privia Health Group had a net margin of 0.89% and a return on equity of 2.52%. The firm’s revenue was up 32.5% compared to the same quarter last year. During the same period last year, the company earned $0.20 EPS. As a group, equities analysts forecast that Privia Health Group will post 0.14 EPS for the current year.

Privia Health Group Company Profile

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.